Glaxosmithkline Consumer Healthcare Holdings DBA Haleon recalls Advil Liqui Gels (minis), Solubilized ibuprofen capsules, 200mg, Pain Reliever Fever Reducer (NSAID), 200 liquid filled

Recalled February 1, 2023 · FDA recall D-0183-2023 · Glaxosmithkline Consumer Healthcare Holdings

Hazard

Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back · FDA Class I

Units

209,292 capsules

Sold at

Nationwide in the USA.

Description

Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back

Product

Advil Liqui Gels (minis), Solubilized ibuprofen capsules, 200mg, Pain Reliever Fever Reducer (NSAID), 200 liquid filled capsules, Pfizer, Madison, NJ 07940, UPC 3 0573 1769 13 5

Manufacturer(s)

Glaxosmithkline Consumer Healthcare Holdings DBA Haleon

Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →